HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4
about
HIV protease inhibitors: a review of molecular selectivity and toxicityIsoform-selective inhibition of facilitative glucose transporters: elucidation of the molecular mechanism of HIV protease inhibitor binding.The SLC2 (GLUT) family of membrane transporters.Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women.In Silico Modeling-based Identification of Glucose Transporter 4 (GLUT4)-selective Inhibitors for Cancer Therapy.GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle.A Novel Fluorescence Resonance Energy Transfer-Based Screen in High-Throughput Format To Identify Inhibitors of Malarial and Human Glucose TransportersNovel Roles for the Insulin-Regulated Glucose Transporter-4 in Hippocampally Dependent Memory.SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy.Investigational protease inhibitors as antiretroviral therapies.Metabolic Disorders in HIV-Infected Adolescents Receiving Protease Inhibitors.Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas.Diabetes and HIV: current understanding and future perspectives.Risk of coronary heart disease in patients with HIV infection.GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters.Glucose transporter 1-mediated glucose uptake is limiting for B-cell acute lymphoblastic leukemia anabolic metabolism and resistance to apoptosis.Superoxide-dependent uptake of vitamin C in human glioma cells.Expression, purification, and functional characterization of the insulin-responsive facilitative glucose transporter GLUT4.Improved adipose tissue function with initiation of protease inhibitor-only ART.The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.Association between the use of protease inhibitors in highly active antiretroviral therapy and incidence of diabetes mellitus and/or metabolic syndrome in HIV-infected patients: A systematic review and meta-analysis.Shuttling glucose across brain microvessels, with a little help from GLUT1 and AMP kinase. Focus on "AMP kinase regulation of sugar transport in brain capillary endothelial cells during acute metabolic stress".Rab-GAP TBC1D4 (AS160) is dispensable for the renal control of sodium and water homeostasis but regulates GLUT4 in mouse kidney.Development of GLUT4-selective antagonists for multiple myeloma therapy.Metabolic Adaptation of Human CD4+ and CD8+ T-Cells to T-Cell Receptor-Mediated Stimulation.Upregulation of Glucose Uptake and Hexokinase Activity of Primary Human CD4+ T Cells in Response to Infection with HIV-1.Metabolic and Cardiac Adaptation to Chronic Pharmacologic Blockade of Facilitative Glucose Transport in Murine Dilated Cardiomyopathy and Myocardial Ischemia.Cellular glucose metabolism is essential for the reduction of cell-impermeable water-soluble tetrazolium (WST) dyes
P2860
Q28082749-7B40DB5F-F3AF-4BF1-B475-63A32193BC95Q33718467-82E0C44C-9CE6-4569-816B-57CCE06C5531Q33926133-C1032299-0F52-4219-ACDE-5C8B44BE5651Q34724872-4922755D-A102-425C-A3AD-FD5D8765F508Q35595838-D53B2FC4-BE6E-41E8-BE61-3BA38623739EQ36156657-A0C7A0AF-D02E-4296-9651-04E40372FA57Q36162383-5DE4C368-80F8-44D6-BBD3-5E694CBD5DD5Q37445092-90B4DA57-244A-4993-B86B-09830171C6C1Q37476025-A6F60B41-BD4D-4C4A-8B9B-0F98C8962EC2Q37582521-F9D938DB-061C-49C6-800A-9AF13302CA10Q37673041-9194669E-05F9-4704-9DC4-CCC98F3BDD00Q37712185-F9B22818-9D74-4240-A98A-C13A5567BE9AQ38085218-F6751208-C891-4723-A9E6-4EA4085C5EE3Q38261508-0A18CA82-C68D-482C-9CED-62547BB0B865Q38663958-1A873DFC-4668-43B7-9057-326717DAEE72Q38947274-BF5FA088-FF9D-4D51-8889-06553EA49537Q39125156-C3ACE589-5285-4722-BBCD-A9CE86F88B43Q39719657-FE0BBFAC-A957-48D9-8C3A-B7DDCC264554Q40578427-58C43C5D-1333-4801-BB39-1E3C06F45C59Q41066112-4276ADEB-BCF3-4EAF-ABBE-0DE03736E42EQ41993494-BF739C6B-17D2-4D26-BA4A-719606D21D2CQ42428665-F84FAB53-B6AF-41F2-BB05-E9887171D10BQ42481916-0C75944E-9465-4108-BE2D-B6D8EF9EA340Q47910184-D23799EC-D407-40A9-9B7B-8C3D61DF8CA8Q49464460-FAA76510-CE1C-4A38-A1CB-7BEED5B59494Q52727826-CB3C3E9B-D729-49E9-8C2C-0AC638365675Q55363508-14CE6F0A-5194-4BD7-A74A-6AED75219962Q58758546-734AD583-8742-4D39-A719-017AEBD4450B
P2860
HIV protease inhibitors act as competitive inhibitors of the cytoplasmic glucose binding site of GLUTs with differing affinities for GLUT1 and GLUT4
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@ast
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@en
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@nl
type
label
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@ast
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@en
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@nl
prefLabel
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@ast
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@en
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@nl
P2860
P3181
P1433
P1476
HIV protease inhibitors act as ...... affinities for GLUT1 and GLUT4
@en
P2093
Paul W Hruz
Richard C Hresko
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0025237
P407
P577
2011-01-01T00:00:00Z